Extrawell Pharmaceutical Holdings Limited (stock code: 00858) provided its Monthly Return on Movements in Securities for January 2026. The total authorised share capital remained at 20,000,000,000 ordinary shares with a par value of HKD 0.01 per share, amounting to HKD 200,000,000. The number of issued shares also stayed unchanged at 2,550,000,000.

The company confirmed compliance with the 25% public float requirement. Under its share option scheme adopted on 2 September 2022, 76,500,000 share options were outstanding as of 31 January 2026, out of a potential 162,500,000 shares issuable upon full exercise. No shares were issued during the reporting period through the exercise of options.

Additionally, zero coupon convertible bonds with a principal amount of HKD 577,170,000 remained in place, convertible into up to 900,000,000 shares at a conversion price of HKD 0.6413. No new shares were issued through conversion of these bonds during January 2026.